全球公司董事会回应危机对管治的挑战 香港董事学会分享全球董事调查2020-2021结果

HONG KONG, May 6, 2021 - (亚太商讯 via SEAPRWire.com) - 一项有关董事会于新冠疫情危机下之管治举措的全球调查发现,三分之二公司董事表示已将投入董事会工作的时间增加50%或以上。香港董事学会今日分享「全球董事学会网络」(即Global Network of Director Institutes,简称「GNDI」)主办的《全球董事调查2020-2021报告》,分析于2020年下半年来自全球17个董事学会近2,000名董事的回应。香港董事学会是GNDI的成员组织,而GNDI是一个由各地首要董事学会所组成的联盟,代表超过150,000名公司董事会成员。香港董事学会主席陶荣博士表示:「GNDI调查报告为我们提供了及时的快映,显示全球董事如何克服新冠疫情危机所带来的经济及社会影响,以及董事如何重新校准董事会焦点及策略,于现在以至可见未来在应对新冠疫情影响方面给予我们很好的参考,因预期疫情将会持续一段时间。全球董事必须及已经采取快速行动应变,这次危机亦提醒他们需要重新思考、重新估值、重新整合、重新开始、重头回弹。」全球主要结果摘要 以下是报告的主要结果摘要:-- 董事给予自己及他们的管理团队评估高分,许多董事响应说由于之前做过模拟情景规划,建立了良好根基,因此可以有效地应付这次新冠肺炎危机。-- 于 2021年及以后,大家将会更加注重风险 ,这次危机极可能带来无比巨大的长期影响, 尤其是董事会于考虑策略、管理风险、评估员工健康与安全等方面。-- 虚拟董事会会议是可行的,但只是次佳选择,虚拟董事会会议亦将会继续流行。挑战与响应GNDI调查报告发表全球统计,香港董事学会亦准备了补充文件,摘录重要议题以全球统计及亚洲及大洋洲(「亚洲及大洋洲」)与香港两分组作并排胪列,根据香港比较结果优次排序,显示在对比区域和世界趋势下的香港情况,给有兴趣的读者参考。结果显示应对新冠疫情危机的最大挑战是「重新调整战略以适应新市场或新环境」(香港:61%,亚洲及大洋洲:61%,全球:56%),其次是「在影响员工、投资者、客户、供货商、社群等的决策中确保有效管治」及「应对不断变化的政府政策和指引」。至于董事会如何应对新冠疫情危机,最常见的答案是「董事会已经能够在新环境中有效地进行管治」(香港:80%,亚洲及大洋洲:84%,全球:89%)。许多董事会已成立特设或特别危机委员会,将其视为「董事会危机应对计划的重要部份」。相对其他地域董事,香港董事多已经于12个月前把流动局限及疫症风险列入「董事会风险仪表板上作为首要风险」,于此方面似乎更为着力,究其因可能是由于他们之前曾经历过2003年SARS及2019年社会动荡获得经验。面对新冠疫情的挑战,香港董事较为注重「快速作出批核或决策」带来的挑战。亦因此更加重视「确保决策能力以解决瞬间移动的问题」,将其视为具有长期影响的管治领域。适应虚拟会议的首要难题很明显是「董事之间失去非言语交流」(香港:61%,亚洲及大洋洲:64%,全球:68%),其次就是「技术问题打乱了会议」,其次就是「技术问题打乱了会议。香港董事学会行政总裁兼GNDI 执行委员会成员徐尉玲博士表示:「全球董事发觉在适应虚拟会议时必须掌握科技,这可能是提醒他们需为提升数码化作好准备。解决新冠疫情危机的挑战有赖数码转型。数码化准备就绪的话有助于转型顺遂,而对数码化有认识的董事会则可带领加速数码化转型。」长期影响对于被认为长远会受到影响的管治领域,许多董事会将着手「将更广阔的风险纳入情景规划中」,并致力「确保员工的持续健康与安全」。受访的董事预计长期趋势有可能改变。受访者预计「将更关注 ESG 、 可持续性和持份者价值问题」(香港:75%,亚洲及大洋洲:71%,全球:67%),他们预计「因更多保护主义而减缓全球化」。于董事会决策流程中,他们着重「纳入数据分析」及「引用外部专家的专长」。他们预期将加强的趋势还包括「增强董事会多元化」、「专业董事的崛起」、「人才竞争加剧」及「更多公司重整宗旨」。陶博士补充:「我们必须继续为迎接业务的严峻艰辛作好准备,我们必须从过去汲取经验、踏上业务模式的变革历程。」汲取经验及展望调查显示,汲取的经验包括「董事会采用数码化行事将是推动董事会向前发展的良好工具」(香港:82%,亚洲及大洋洲:87%,全球:89%)。受访者表示,董事会将会「将更广阔的风险纳入董事会的信息仪表板」、「确保与更多持份者进行更好沟通」及「加强董事教育、认识阻碍企业应对新冠疫情的因素」等。徐博士补充:「胜任的董事必须追求持续专业进修。这项调查的结果为香港董事学会提供参考,提示我们如何加强教育,以在新常态之下促进董事的工作。」香港董事学会每年举办「杰出董事奖」表扬杰出的董事及董事会,从而推广卓越董事常规。奖项已踏入第二十一届,今年以「在新常态中领航」为主题,现正接受公众提名。GNDI 全球董事调查2020-2021报告全文[http://www.hkiod.com/gndisurvey2020.pdf]及香港董事学会的补充文件[http://www.hkiod.com/gndisurvey2020/sup.pdf]可免费下载。欢迎提名竞逐2021年度杰出董事奖[http://www.hkiod.com/dya-current.html]。香港董事学会简介香港董事学会(简称“HKIoD”或「学会」)为香港代表专业董事的首要组织,其宗旨是促进所有公司的持久成就;为达成使命,学会致力提倡优秀企业管治与厘订相关标准,以及协助董事的专业发展。凭借由来自上市公司及非上市公司的董事组成之会员基础,学会致力为董事提供教育项目及信息服务,并代表董事发声。学会具国际视野及多元文化,采用两文三语经营业务。香港董事学会为「全球董事学会网络」即Global Network of Director Institutes的成员,该联盟汇集世界各地代表董事的翘楚学会。网址 http://www.hkiod.com 电话: (852) 2889 9986 传真: (852) 2889 9982关于全球董事学会网络(「GNDI」) 「全球董事学会网络」,即Global Network of Director Institutes,简称GNDI,是一个由各地首要董事学会所组成的联盟,提供环球互惠,以协助董事及董事会接触国际资源,目前拥有包括香港董事学会在内共22个成员组织,世界性代表超过150,000名董事及管治专业人士。传媒查询:香港董事学会任绮欣 (852) 2889 1414/ joanne.yam@hkiod.com苏佩君 +852 2889 4988/odessa.so@hkiod.com纵横公共关系顾问集团有限公司陈练 (852) 2114 4396/ brenda.chan@sprg.com.hk 邱泽勤 (852) 2114 4395/ chak.yau@sprg.com.hk Copyright 2021 亚太商讯. All rights reserved. (via SEAPRWire)

Consumer watchdog Case gets new executive director

SINGAPORE - The Consumers Association of Singapore (Case) has appointed a new executive director. In a statement on Monday (April 19), the consumer watchdog announced that Ms Lee Siow Hwee replaced incumbent Loy York Jiun at the beginning of the month. Mr Loy, 47, has returned to the National Trades Union Congress, from which he was seconded as deputy executive director of Case on April 1, 2016. He was appointed as executive director in 2017. Ms Lee, 42, has served in the People's Association for 18 years in roles, including as deputy general manager of Central Singapore Community Development Council as well as constituency director of Moulmein-Cairnhill and Jurong Central constituency offices. During the peak of the Covid-19 pandemic last year, she led several national assistance schemes to support affected households and local businesses in central Singapore. These included the CDC Student Meals Scheme, which helped families living in flats under the Public Rental Scheme with children studying in primary and secondary schools defray the cost of buying meals while on home-based learning. Case president Lim Biow Chuan said: "With Siow Hwee's extensive experience in working with stakeholders and connecting with residents on the ground, I am confident that she will build on York Jiun's good work to educate and empower consumers in these challenging times." He also thanked Mr Loy for his contributions to the consumer movement. Under Mr Loy's leadership, Case ramped up efforts to educate consumers on their rights, especially in the area of e-commerce purchases, and took firm action against errant e-commerce retailers. In 2019, Case flagged retailer Fashion Interactive for misleading its consumers with fine print and for automatically enrolling them into a membership on its footwear website. Mr Loy has been credited with working closely with Enterprise Singapore and the Singapore Standards Council to launch the Republic's first e-commerce standard, Technical Reference 76, which allows consumers to access transparent product and pricing information. He also enhanced Case's efforts to help consumers make informed purchasing decisions by operationalising price comparison platforms Price Kaki and Fuel Kaki. Mr Lim added: "On behalf of the Case central committee, management and staff, I would like to thank York Jiun for his contributions in the last five years. "He pushed hard for consumers to be protected and oversaw Case's strategic shift in its approach of educating consumers amid an evolving consumer landscape."

HKIoD Recommends a Director Identification Number System

HONG KONG, Apr 7, 2021 - (ACN Newswire via SEAPRWire.com) - The Government has plans to introduce subsidiary legislation to implement provisions under the Companies Ordinance relating to legitimate and necessary access to personal information contained in the Companies Register. The Hong Kong Institute of Directors supports the new arrangement. Under the new arrangement, public inspection of the Companies Register will not be precluded. The Companies Ordinance does enable public inspection of data in the Companies Register, but the inspection must comport with the law. The Companies Ordinance as passed into law contains provisions specifying that public inspection of the Companies Register should only be for the purposes set out in section 45(1). A main purpose of public inspection of the Companies Register is to ascertain the identity of a director of a certain company.Under the new arrangement, a director may provide a correspondence address to be displayed in the Companies Register, and only a part of the identification numbers will be on display. The data so displayed should in most ordinary circumstances enable the person seeking information to ascertain the identity of a director. For service of documents and legal proceedings, the company's registered address or another service address that the director provides is sufficient. Under the new arrangement, there will also be a mechanism to enable Specified Persons (e.g., minority shareholders, financial institutions, certain professional bodies, employees who are owed back wages, etc.) to seek court approval to obtain a director's usual residential address and identification number in full. A court may grant such access if deemed appropriate. The Companies Registry may also disclose a director's usual residential address if the CR cannot establish contact with the director using the correspondence address provided. Government departments and law enforcement agencies may also obtain full personal details of a director through the CR for law enforcement.HKIoD is all for accountability of company directors, but the accountability need not come from open access to a director's residential address or to the director's personal identification number in full. The key is to have ways to ascertain the identity of a director. Under the new arrangement, the public will have adequate channels to obtain information to prevent directors from being held accountable or getting away with wrongdoings.We may still borrow from other jurisdictions to make it more convenient to ascertain a director's identity without attracting abuse of personal information. We can look to Australia, and consider introducing official, unique Director Identification Numbers to be used by the same director across different entities for the duration of the director's life. Such DIN will improve traceability of a director's involvement across different entities at different times. Such traceability would especially help tackle phoenix activities, making it harder for culpable directors to hide. But for the upstanding director, a DIN will not be a burden and can indeed signify one's credibility. About The Hong Kong Institute of DirectorsThe Hong Kong Institute of Directors ("HKIoD") is Hong Kong's premier body representing directors to foster the long-term success of companies through advocacy and standards-setting in corporate governance and professional development for directors. A non-profit-distributing organisation with membership consisting of directors from listed and non-listed companies, HKIoD is committed to providing directors with educational programmes and information service and establishing an influential voice in representing directors. With international perspectives and a multi-cultural environment, HKIoD conducts business in biliteracy and trilingualism. HKIoD is a member institute of the Global Network of Director Institutes, a worldwide alliance of leading director institutes.Website: http://www.hkiod.com. Media Enquiries: Ms Joanne Yam +852 2889 1414 joanne.yam@hkiod.comMs Odessa SO +852 2889 4988 odessa.so@hkiod.com Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)

Former SMU associate director charged with accepting $472,000 in bribes

SINGAPORE - A former Singapore Management University (SMU) associate director was on Tuesday (March 23) charged with accepting $472,000 in bribes. Christopher Tan Toh Nghee had allegedly accepted illegal funds from three men to advance their business interests with the university between August 2017 and November 2019. The 43-year-old faces 50 charges for offences under the Prevention of Corruption Act. The three men, who were also charged on Tuesday, are International Alliance Marketing director Kenneth Lum Hsien Loong, CJ Synergy director Cher Kheng Than and Assetualize managing director Jeffery Long Chee Kin. International Alliance Marketing director Kenneth Lum Hsien Loong (left) and CJ Synergy director Cher Kheng Than were also charged on March 23. ST PHOTOS: KELVIN CHNG Lum faces 35 charges for offering the bribes, while Long and Cher face eight and seven charges respectively for such offences. Tan and Cher also each face one charge of giving false information to the Corrupt Practices Investigation Bureau (CPIB) and one charge of intentionally obstructing the course of justice. According to court documents, Tan had allegedly given false information to CPIB officers that the money given to him by Cher was for the repayment of a loan. Tan also allegedly deleted an electronic note from his mobile phone that contained records of the payments he had received and expected to receive from Lum, Cher and Long. Cher had allegedly deleted WhatsApp chat logs with Tan and an electronic note from his phone that contained records of payments he gave to Tan. All four will return to court on April 20. The Straits Times has contacted SMU for comments on the case. For each count of corruption, offenders can be jailed for up to five years or fined up to $100,000, or both. For giving false information relating to corruption offences, a person may be jailed for up to a year or fined up to $10,000, or both. A person convicted of intentionally obstructing the course of justice can be jailed for up to seven years or fined, or both. More on this topic   Related Story 3 former Shell employees linked to $200m gas oil heist charged with graft   Related Story 16 months' jail for woman involved in business deal that paid out nearly $500k in bribes

Honda Motor Co., Ltd. Announces New President & CEO

TOKYO, Feb 19, 2021 - (JCN Newswire) - Honda Motor Co., Ltd. announced that at a meeting of the company's Board of Directors held today, Toshihiro Mibe, currently the company's Senior Managing Director, was named the next President and Representative Director, effective April 1, 2021. Mibe will succeed Takahiro Hachigo, the current President and Representative Director, who will become a Director, effective April 1, 2021.Mibe is scheduled to become Director, President and Representative Executive Officer* (CEO) with the resolution of the Ordinary General Meeting of Shareholders scheduled to be held in June 2021, at which time Hachigo will retire from the company.During the approximately six years since he ascended to the presidency in 2015, in the face of a period of great transformation of the company's business environment, Hachigo took the initiative and formulated Honda's 2030 Vision to enable Honda to become "a company society wants to exist" into the future. For the fulfilment of the company's 2030 Vision statement - "to serve people worldwide with the joy of expanding their life's potential" -- Hachigo led Team Honda on a course to "solidify existing businesses" and "prepare for future growth." Under Hachigo's leadership, Honda has increased efficiency and strengthened its operating structure in the areas of production and product development. Moreover, by pursuing the "selection and concentration" of its corporate resources on a global basis, a solid foundation for the future was established, preparing Honda to take off in the new era.Mibe, who is set to assume the presidency in April, joined Honda in 1987 and has been primarily focused on the research & development of automobiles, particularly powertrain development. In 2019, Mibe became the President and Representative Director of Honda R&D Co., Ltd., and since 2020, Mibe has been concurrently serving as Senior Managing Director of Honda Motor Co., Ltd.In this transformational era, a new value system is spreading all around the world. Reflecting this direction, under the new management structure Honda will strive to achieve continuous growth and advancement by further enhancing its commitment toward solving social issues based on Honda's belief that "the purpose of technology is to help people," which remains unchanged since the foundation of the company. Honda appreciates the high expectations people worldwide have for Honda which will grow and advance hand-in-hand with society.*New title name in accordance with the transition to a company with three committees after receiving approval at the Ordinary General Meeting of Shareholders scheduled to be held in June 2021 Copyright 2021 JCN Newswire. All rights reserved. www.jcnnewswire.com

WARC launches Prize for MENA Strategy 2021

LONDON, Feb 1, 2021 - (ACN Newswire) - WARC, the global authority on marketing effectiveness, has today launched the 2021 WARC Prize for MENA Strategy, a search for the best strategic thinking from the region's marketing industry that has driven results.Jury Chair: Peter DeBenedictis, MicrosoftNow in its fifth year, this case study competition is free to enter and is open to agencies, brand owners and specialists in any marketing discipline.This year's competition will be chaired by Peter DeBenedictis, Chief Marketing Officer, Middle East and Africa, Microsoft. Having lived and worked in the Middle East for more than 30 years, Peter has deep experience of growing business in diverse Emerging Markets. Before Microsoft, he led the marketing function for several of the world's leading brands, where he managed multiple investment programmes to drive top-line growth. Commenting on the awards, Peter DeBenedictis, said: "The ability to combine the art and science of marketing is one of many new challenges facing marketers today, and strategic thinking plays a key role in it. The WARC Prize for MENA Strategy leaves 'marketing for marketing's sake' to the side to shine a spotlight on effective work the industry can draw inspiration from." Joining Peter DeBenedictis are an eminent judging panel of strategy experts and senior marketers. The 17-strong jury is as follows:- Peter DeBenedictis, Chief Marketing Officer, Middle East and Africa, Microsoft - (Jury Chair)- Hind AbuAlia, SVP, S4Capital/MediaMonks- Rohit Arora, Business Director & Head of Strategy, Liwa Content Driven- Laura Chaibi, Senior Consultant, Global Media, Nielsen Media Middle East- Stacy Fisher, Head of Digital Transformation & Innovation, Publicis Groupe- Noor Hassanein, Strategy Director, Impact BBDO- Shagorika Heryani, Head of Strategy, Grey MENA- Ali Khalil, Strategic Planning Director, Wunderman Thompson KSA- Roxane Magbanua, Business Unit Director, PHD UAE- Mir Damoon Mir, Chief Creative Officer and Founder, Zigma8- Stewart Morrison, Managing Director, MENA, FirmDecisions- Hossam Omar, Director of Brand and Marketing Communications, Etisalat- Fahad Osman, Regional Director, Global Business Marketing, MENAT, TikTok- Dewald du Plooy, Marketing Director MENA, Yum! Restaurants International- Tahaab Rais, President - SLC and Regional Head of Strategy & Truth Central, FP7 McCann MENAT- Kalika Tripathi, Head of Marketing MENA, Visa- Nancy Villanueva, CEO, Iberia & Middle East, InterbrandThe jury will award a Grand Prix, Gold, Silver and Bronze accolades as well as five Special Awards recognising specific areas of excellence, two of which are new for this year:- The Long-Term Strategy Award (new) - for the best strategy designed to build a long-term brand platform, executed over a period of three years or more.- The Pivot to Digital Award (new) - for the best example of a brand digitising its products or services.- The Research Excellence Award - for the best use of research in the development of strategic ideas.- The Brand Rebel Award- for the best example of a campaign departing from category norms.- The Local Hero Award - for the best example of a challenger brand from the MENA region using smart marketing strategy to take on bigger competitors.Chiara Manco, Commissioning Editor, Case Studies, WARC, says: "We are delighted to be working with such a distinguished panel to bring to the forefront the very best of the region's strategic thinking that is helping clients solve problems and providing a base for future growth."The deadline to submit entries is 28 April. More information about the awards, including jury bios and how to enter is available on www.warc.com/awards/warc-prize-for-mena-strategyContact:Amanda Benfell Head of PR & Press +44 20 7467 8125 Copyright 2021 ACN Newswire. All rights reserved. www.acnnewswire.com

Health Check Podcast: Get healthy living tips for 2021

Fortnightly on Wednesdays, get healthier living tips as The Straits Times' senior health correspondent Joyce Teo chats with expert guests. These are the best episodes of our Health Check Podcast series so far. Health Check Ep 6: Can soursop or ketogenic diets be used to treat and control cancer? (featuring Dr Wong Seng Weng, medical director and consultant medical oncologist at The Cancer Centre) Health Check Ep 45: How to age well and achieve a lower biological age (featuring anti-ageing expert, Prof Brian Kennedy, the director of the NUHS Centre for Healthy Longevity) Health Check Ep 46: Is there such a concept as an anti-ageing diet? (featuring anti-ageing expert, Prof Brian Kennedy, the director of the NUHS Centre for Healthy Longevity) Health Check Ep 15: Forget about raising your good cholesterol? (featuring  Dr Michael Lim, the medical director of MWH Heart, Stroke & Cancer Centre) Health Check Ep 39: Smokers at higher risk during Covid-19 times (featuring Dr Lambert Low, a consultant at the National Addictions Management Service at the Institute of Mental Health) Health Check Ep 16: How to get your hawker food fix without risking a heart attack (featuring Dr Michael Lim, the medical director of MWH Heart, Stroke & Cancer Centre, who's also the honorary president of the Asian Society of Cardiology) Health Check Ep 38: Stress fractures from running too much during Covid-19 pandemic? (featuring Dr Tan Ken Jin, an orthopaedic surgeon at Mount Elizabeth Novena Hospital) Health Check Ep 5: Can coffee or a piping hot cup of tea increase your risk of cancer? (featuring Dr Wong Seng Weng, medical director and consultant medical oncologist at The Cancer Centre) Subscribe to Health Check Podcast channel, hear the latest episodes fortnightly on Wednesdays and rate us on your favourite audio apps: Channel: https://str.sg/JWaN Apple Podcasts: https://str.sg/JWRX Spotify: https://str.sg/JWaQ Website: http://str.sg/stpodcasts Google Podcasts: https://str.sg/J6Wv  Feedback to: podcast@sph.com.sg Read Joyce Teo's stories: https://str.sg/JbxN

Xu Chong, CFO & Executive Director of Babytree: Focusing on M&C and Expanding Horizons for More Opportunities

HONG KONG, Dec 3, 2020 - (ACN Newswire) - Joining the maternity and child (M&C)-focused Babytree Group (1761.HK) was the right thing to do for Xu Chong, CFO and Executive Director of the company. Xu Chong, CFO and Executive Director of Babytree Group"I tried to find the right business from an investor perspective. And Babytree, a top-ranking company in the 600 billion dollar M&C industry with an unrivalled reputation and high user traffic, is exactly what I've been looking for," said Mr. Xu in an interview with a reporter from takungpao.com. In fact, as one of the largest and most active M&C-focused community platforms in China, Babytree has achieved impressive results in the past year in content upgradation and product innovation through relentless efforts. Data show that as of 30 June 2020, the monthly active users (MAUs) of Babytree reached 103 million, among which the MAUs of the Babytree Parenting mobile app amounted to 20.4 million, up 7.9% from the end of 2019, with the retention rate (the percentage of active users on the app in a specific month that remained active users in the next month) increasing to 65.2%. Thanks to refinements and upgrades in products, services and experience, Babytree remained a user traffic leader in the industry during the first half of the year and has ushered in a new stage of "value creation-driven growth". In terms of products, the company continued to launch innovative products to boost sales, in addition to constantly building the content-, tools- and community-focused competitiveness of its products. Centering around "M&C User Lifestyle Showcase", a string of upgrades were rolled out for the Babytree Parenting app, the flagship product of the company. Meanwhile, Babytree is set to see the second curve of growth through building content for various scenarios and cultivating its IP portfolio. For example, the Douyin account, "Babytree Experts", has attracted nearly 700,000 subscribers, with over 6,500,000 views for one of the videos released. "As the CFO, it is my duty to protect cash flow and keep the company going at this difficult time." Looking back at the COVID-19 pandemic early this year, which is surely a Black Swan event for Babytree Group and the M&C market, Xu Chong said that in spite of the impacts of the pandemic, M&C demand remains strong and the recession-resistant nature of the industry will serve as the underpinning for its market size and investment value. Meanwhile, the M&C industry is faced with the new challenge of advancing digitalization. "As the CFO, my definition of safety is that the company can survive at least two of such crisis as the pandemic. And that's how I design our asset structure. By doing so, we will have sufficient cash flow to keep the company going in an unexpected crisis like the pandemic. Meanwhile, be friends with time and note that chance favours the prepared mind. We must be able to anticipate what's ahead, a peak or a trough or a crisis. When a crisis occurs, I have to do what needs to be done as a CFO, including cost actions or urging the business team to make innovative breakthroughs. More importantly, have forward-looking strategies," said Xu Chong. He also added that as a top-ranking M&C-focused online platform that has been providing diverse services including knowledge, tools and shopping for Chinese families, Babytree has advantageous accumulations of data and insights to help offer effective, differentiated products and services during the pandemic and relieve consumer anxiety in respect of supply. By continuing to provide solutions, create value for and offer companionship to users, the company is poised to grow sustainably. "Only a company with a vision and blueprint to draw future lifestyles for users and investors can be trusted with higher value expectations." As the CFO of a Mainland China company listed in Hong Kong, Mr. Xu shared with takungpao.com his insights about the Hong Kong capital market and what it takes to be a good listed company. According to him, reforms of the Stock Exchange of Hong Kong's systems have resulted in more inclusiveness and openness and have removed barriers to new economy or already overseas-listed companies that are looking to go public in the Hong Kong market. Now these companies can get access to diversified financing from home and abroad, while investors have more choices as to where to put their money. It is a win-win for everyone involved. In 2020, despite new uncertainties to the capital market brought by Black Swan events such as the pandemic, an increasing number of already overseas-listed and new economy companies became listed in Hong Kong. With the thriving Chinese economy, more budding industries and companies in the country start to be noticed by global investors. In the future, the Stock Exchange of Hong Kong, a shining star in the global capital market, is expected to gather more quality assets to create higher value for investors. As to what it takes to be a good listed company, Mr. Xu mentioned three elements, namely a promising industry outlook, sound corporate fundamentals, and excellent corporate governance. Firstly, the company must be in an industry with great potentials, fast growth and strong resistance to recessions. Secondly, the company must do good in position in the industry, quality of products and services, reputation among consumers, profit model, core values, competition, financial indicators and so on. Finally, excellent corporate governance delivers a more solid performance of the company. "Capital value is above all reflected in value created for users. A company that puts value creation for users first should incorporate technologies and services into daily life, solve problems for users, promote convenient access to information and resources, eliminate pain points or empower the industry. A company with a vision and blueprint to draw future lifestyles for users and investors will be trusted by investors with higher value expectations in that it can generate strong, consistent returns for its shareholders," said Xu. "A good CFO should also be an expert of business, not just an expert of numbers."Years of professional experience in accounting and financial management have made Xu Chong the right person for the job as CFO & Executive Director of Babytree Group. He believed that to be a good CFO, one needs to be a finance professional first, with excellent skills in data analysis, leadership, project management, finance techniques, etc. Meanwhile, a good CFO should also be an expert of business, not just an expert of numbers. He must dive deep into the industry and the business operations to get insights about changes and trends, as part of his efforts to make better planning for the company, whether for the short, medium or long haul, as well as to contribute to the healthy, sustainable development of the company. "Looking ahead, we all need to keep learning, upgrading our skills, and expanding our horizons in pursuit of more opportunities," said Mr. Xu. Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Avance Clinical Wins MasterControl 2020 Innovation Excellence Award

ADELAIDE, AU, Oct 30, 2020 - (ACN Newswire) - The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical today accepted the MasterControl 2020 Innovation Excellence Award in a virtual ceremony.L-R: Priyanka Chamoli, Director Quality Assurance, Emma Woolman, Senior Compliance and Training Officer, Yvonne Lungershausen, Avance Clinical's CEO, and Lisa Eglinton, Director Compliance and Training.Avance Clinical made the announcement today at AusBiotech 2020 (28 - 30 October, 2020).https://www.ausbiotechnc.org/Avance Clinical CEO Yvonne Lungershausen said the company was very pleased to be awarded such recognition by MasterControl, a leader in the clinical digital management technology. The MasterControl Clinical Excellence solution streamlines eTMF management and helps clients achieve real-time visibility into critical clinical processes across operational teams - all on one centralized platform. https://www.mastercontrol.com/clinical/"The award acknowledges our leadership as Australia's biotech CRO and it provides further confidence to our clients that we are serious about delivering quality clinical research services by being nimble and adaptive, and by utilising state-of-the-art systems that are compliant with industry standards, such as MasterControl eQMS," said Yvonne Lungershausen."Avance Clinical invests significantly in the industry's leading clinical technologies making it one of the most advanced CROs globally for digital clinical research management and eClinical solutions." On presenting the Innovation Excellence Award, MasterControl said the award recognises "the power of innovation and celebrates companies who feel the same way we do, who are not afraid to shed the status quo to find their own path and who push boundaries and spearhead important changes within their industries. Companies driven by innovation who truly live and breathe it."Avance Clinical Director Quality Assurance, Priyanka Chamoli, said:"Receiving the award from MasterControl is a testament of our commitment to invest in our Quality Management System and to continually improve and strengthen it. This Award recognises and provides visibility to our efforts to push boundaries and adopt this significant change not just for the Quality Assurance department but across-the-board in the organisation.""MasterControl eQMS enables accurate, streamlined processes for Document Control and Training. Avance Clinical, which is on a significant growth trajectory, requires robust procedures as part of our QMS. MasterControl has allowed our staff to create/review and access our controlled documents in real-time and the automated link between different modules enables timely delivery of training."Avance Clinical Director Compliance and Training, Lisa Eglinton said:"MasterControl Training Module provides a robust, user-friendly method for the delivery of role-specific training programs to all staff. The system provides a real-time indication of training status to Trainees and their Line Managers which ensures training compliance across the company."Avance Clinical is the leading Australian owned CRO that has been providing high-quality clinical research services fit for global regulatory standards to the local and international drug development industry for 20 years.Considering Australia? Contact us about your next study. https://www.avancecro.com/eclinical-solutions/See Image here http://bit.ly/AvanceClinicalMasterControl(From left to right) Priyanka Chamoli, Director Quality Assurance, Emma Woolman, Senior Compliance and Training Officer, Yvonne Lungershausen, Avance Clinical's CEO, and Lisa Eglinton, Director Compliance and Training.About Avance Clinical www.avancecro.comAustralia's Avance Clinical has more than 20-years of experience and is now one of Australia's leading Contract Research Organizations. Avance Clinical is committed to providing high-quality clinical research services with its highly-experienced team.The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of experts who also demonstrate passion in their chosen field.Avance Clinical offers high-quality services in an established clinical trial ecosystem, that includes world-class Investigators and Sites able to access specialized patient groups. Other benefits include:1. The Government R&D grant means up to 43.5% rebate on clinical trial spend2. eClinical solutions - speed and continuity3. Site Initiation Visit (SIV) and Study Start achieved in 5 - 6 weeks4. No IND required for clinical trials5. Full GMP material is not mandated for Phase I clinical trials6. Established clinical trial environment with world-class Investigators and sites7. Established healthy subject databases and specialized patient populations8. Five independent Phase 1 facilities across Australia including hospital-based units for critical care9. Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track-record in FDA compliant research10. Seasonal studies: Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia's counter-flu and allergy seasonsMedia Contact: media@avancecro.comChris Thompson Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com